In this context, the interaction between ‘traditional’ metabolic risk factors—especially obesity and T2DM—with the PNPLA3 rs738409 C > G variant can account for the observed variation in disease progression and natural contribute to MASLD heterogeneity. This evidence concerns the gene PNPLA3 and type 2 diabetes mellitus.